Review



primary adult human aortic endothelial cells haecs  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC primary adult human aortic endothelial cells haecs
    Primary Adult Human Aortic Endothelial Cells Haecs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 475 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary adult human aortic endothelial cells haecs/product/ATCC
    Average 96 stars, based on 475 article reviews
    primary adult human aortic endothelial cells haecs - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    ATCC primary adult human aortic endothelial cells haecs
    Primary Adult Human Aortic Endothelial Cells Haecs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary adult human aortic endothelial cells haecs/product/ATCC
    Average 96 stars, based on 1 article reviews
    primary adult human aortic endothelial cells haecs - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    ATCC human adult aortic endothelial primary cells haecs human adult aortic endothelial cells
    Human Adult Aortic Endothelial Primary Cells Haecs Human Adult Aortic Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human adult aortic endothelial primary cells haecs human adult aortic endothelial cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    human adult aortic endothelial primary cells haecs human adult aortic endothelial cells - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    ATCC human adult aortic endothelial cells haecs
    a Expression of AJSZ in HDFs. Immunostaining for AJSZ is shown in red and fibroblast markers Vimentin (VIM) or Transgelin (TAGLN) are shown in green. Nuclei are stained with DAPI. n = 4 per condition. b Quantification of the % of cardiac marker ACTN2-expressing cells normalized to MGT + siControl condition after 30 days of cardiac reprogramming in HDFs. n = 5 and n = 9 for siControl and siAJSZ treated, respectively. c Representative images of HDFs treated with MGT + siControl or MGT + siAJSZ and immunostained for cardiac (ACTN2, green) and fibroblast (TAGLN, red) markers. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. d Quantification of the % of MAP2 (green) and TUJ1 (red)-double-positive cells, 3 days after overexpression of Ascl1, Brn2, and Mytl1 (ABM) in HDFs. n = 7 and n = 8 for siControl and siAJSZ treated, respectively. e Representative images of HDFs treated with ABM + siControl or ABM + siAJSZ and immunostained for MAP2 (green) and TUJ1 (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate TUJ1 + MAP2 + double-positive cells = neurons. f Quantification of the % of NANOG-positive cells, 7 days after overexpression of OCT4, KLF4, SOX2, and cMYC (OKSM) in HDFs. n = 10 per condition. g Representative images of HDFs treated with OKSM + siControl or OKSM + siAJSZ and immunostained for pluripotent marker NANOG (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate NANOG-positive cells= iPSCs. h Quantification of the % of ACTN2 + 20 days after MGT overexpression. i Representative images of <t>HAECs</t> treated with MGT + siControl or MGT + siAJSZ and immunostained for the <t>endothelial</t> marker (PECAM1, red) and the cardiac marker (ACTN2, green). n = 4 per condition. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. Scale bars: 50 µm. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in figure are presented as mean values ± standard deviation.
    Human Adult Aortic Endothelial Cells Haecs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human adult aortic endothelial cells haecs/product/ATCC
    Average 96 stars, based on 1 article reviews
    human adult aortic endothelial cells haecs - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    TCS Cellworks primary adult human aortic endothelial cells (haecs)
    a Expression of AJSZ in HDFs. Immunostaining for AJSZ is shown in red and fibroblast markers Vimentin (VIM) or Transgelin (TAGLN) are shown in green. Nuclei are stained with DAPI. n = 4 per condition. b Quantification of the % of cardiac marker ACTN2-expressing cells normalized to MGT + siControl condition after 30 days of cardiac reprogramming in HDFs. n = 5 and n = 9 for siControl and siAJSZ treated, respectively. c Representative images of HDFs treated with MGT + siControl or MGT + siAJSZ and immunostained for cardiac (ACTN2, green) and fibroblast (TAGLN, red) markers. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. d Quantification of the % of MAP2 (green) and TUJ1 (red)-double-positive cells, 3 days after overexpression of Ascl1, Brn2, and Mytl1 (ABM) in HDFs. n = 7 and n = 8 for siControl and siAJSZ treated, respectively. e Representative images of HDFs treated with ABM + siControl or ABM + siAJSZ and immunostained for MAP2 (green) and TUJ1 (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate TUJ1 + MAP2 + double-positive cells = neurons. f Quantification of the % of NANOG-positive cells, 7 days after overexpression of OCT4, KLF4, SOX2, and cMYC (OKSM) in HDFs. n = 10 per condition. g Representative images of HDFs treated with OKSM + siControl or OKSM + siAJSZ and immunostained for pluripotent marker NANOG (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate NANOG-positive cells= iPSCs. h Quantification of the % of ACTN2 + 20 days after MGT overexpression. i Representative images of <t>HAECs</t> treated with MGT + siControl or MGT + siAJSZ and immunostained for the <t>endothelial</t> marker (PECAM1, red) and the cardiac marker (ACTN2, green). n = 4 per condition. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. Scale bars: 50 µm. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in figure are presented as mean values ± standard deviation.
    Primary Adult Human Aortic Endothelial Cells (Haecs), supplied by TCS Cellworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary adult human aortic endothelial cells (haecs)/product/TCS Cellworks
    Average 90 stars, based on 1 article reviews
    primary adult human aortic endothelial cells (haecs) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Expression of AJSZ in HDFs. Immunostaining for AJSZ is shown in red and fibroblast markers Vimentin (VIM) or Transgelin (TAGLN) are shown in green. Nuclei are stained with DAPI. n = 4 per condition. b Quantification of the % of cardiac marker ACTN2-expressing cells normalized to MGT + siControl condition after 30 days of cardiac reprogramming in HDFs. n = 5 and n = 9 for siControl and siAJSZ treated, respectively. c Representative images of HDFs treated with MGT + siControl or MGT + siAJSZ and immunostained for cardiac (ACTN2, green) and fibroblast (TAGLN, red) markers. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. d Quantification of the % of MAP2 (green) and TUJ1 (red)-double-positive cells, 3 days after overexpression of Ascl1, Brn2, and Mytl1 (ABM) in HDFs. n = 7 and n = 8 for siControl and siAJSZ treated, respectively. e Representative images of HDFs treated with ABM + siControl or ABM + siAJSZ and immunostained for MAP2 (green) and TUJ1 (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate TUJ1 + MAP2 + double-positive cells = neurons. f Quantification of the % of NANOG-positive cells, 7 days after overexpression of OCT4, KLF4, SOX2, and cMYC (OKSM) in HDFs. n = 10 per condition. g Representative images of HDFs treated with OKSM + siControl or OKSM + siAJSZ and immunostained for pluripotent marker NANOG (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate NANOG-positive cells= iPSCs. h Quantification of the % of ACTN2 + 20 days after MGT overexpression. i Representative images of HAECs treated with MGT + siControl or MGT + siAJSZ and immunostained for the endothelial marker (PECAM1, red) and the cardiac marker (ACTN2, green). n = 4 per condition. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. Scale bars: 50 µm. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in figure are presented as mean values ± standard deviation.

    Journal: Nature Communications

    Article Title: Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells

    doi: 10.1038/s41467-023-37256-8

    Figure Lengend Snippet: a Expression of AJSZ in HDFs. Immunostaining for AJSZ is shown in red and fibroblast markers Vimentin (VIM) or Transgelin (TAGLN) are shown in green. Nuclei are stained with DAPI. n = 4 per condition. b Quantification of the % of cardiac marker ACTN2-expressing cells normalized to MGT + siControl condition after 30 days of cardiac reprogramming in HDFs. n = 5 and n = 9 for siControl and siAJSZ treated, respectively. c Representative images of HDFs treated with MGT + siControl or MGT + siAJSZ and immunostained for cardiac (ACTN2, green) and fibroblast (TAGLN, red) markers. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. d Quantification of the % of MAP2 (green) and TUJ1 (red)-double-positive cells, 3 days after overexpression of Ascl1, Brn2, and Mytl1 (ABM) in HDFs. n = 7 and n = 8 for siControl and siAJSZ treated, respectively. e Representative images of HDFs treated with ABM + siControl or ABM + siAJSZ and immunostained for MAP2 (green) and TUJ1 (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate TUJ1 + MAP2 + double-positive cells = neurons. f Quantification of the % of NANOG-positive cells, 7 days after overexpression of OCT4, KLF4, SOX2, and cMYC (OKSM) in HDFs. n = 10 per condition. g Representative images of HDFs treated with OKSM + siControl or OKSM + siAJSZ and immunostained for pluripotent marker NANOG (red). Nuclei are stained with DAPI (blue, top left insets). White arrows indicate NANOG-positive cells= iPSCs. h Quantification of the % of ACTN2 + 20 days after MGT overexpression. i Representative images of HAECs treated with MGT + siControl or MGT + siAJSZ and immunostained for the endothelial marker (PECAM1, red) and the cardiac marker (ACTN2, green). n = 4 per condition. Nuclei are stained with DAPI (blue). White arrows indicate iCMs. Scale bars: 50 µm. Student’s t -test: * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in figure are presented as mean values ± standard deviation.

    Article Snippet: Human adult aortic endothelial cells (HAECs) were obtained from ATCC (PCS-100-011) and cultured in plates precoated with 0.1% gelatin in Vascular Cell Basal Medium (VCBM; ATCC, PCS-100-030) containing endothelial cell growth kit-BBE (ATCC, PCS-100-040) and 0.1% P/S.

    Techniques: Expressing, Immunostaining, Staining, Marker, Over Expression, Two Tailed Test, Standard Deviation

    a Schematic depicting the hypothesis that AJSZ promotes the expression of reprogramming barriers. b Volcano plot showing the screening results for siRNAs directed against top 25 percentile downregulated (MGT + siAJSZ vs MGT) and core promoter-bound genes in the iMGT-MEF CR assay. The top three candidate barrier genes are circled. n = 4 per condition. c Histogram showing validation of siNceh1 and siChst2 effect on CR. n = 8 per condition. d Representative images for siControl, siChst2, and siNceh1 conditions. Myh6-eGFP+ cells are shown in green and cell nuclei are stained blue (DAPI, top right insets). e Schematic depicting the hypothesis that AJSZ negatively regulates reprogramming agonists. f Volcano plot showing the screening results for siRNAs directed against the top 25 percentile of upregulated (MGT + siAJSZ vs MGT) and core promoter-bound genes in siAJSZ-induced iMGT-MEF assay. g Histogram showing validation of top nine siRNAs that blunt siAJSZ-induced CR without affecting cell viability. n = 4 per condition. h Representative images for siAJSZ+ siControl, siMef2c, siHspb3, or siOlfml3 conditions. i Heatmap summarizing AJSZ expression dependence of identified barriers and agonists in HAECs and HDFs, 2 days after MGT, ABM, or OKSM overexpression. j Model showing that AJSZ regulates cell fate reprogramming by controlling the expression of a conserved set reprogramming agonists. Scale bars: 50 µm. Student’s t -test. * p < 0.05, ** p < 0.01, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in the figure are presented as mean values ± standard deviation. j Schematic is modified from Cunningham, T. J. et al. Id genes are essential for early heart formation. Genes & development, 10.1101/gad.300400.117 (2017). - CC-BY 4.0.

    Journal: Nature Communications

    Article Title: Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells

    doi: 10.1038/s41467-023-37256-8

    Figure Lengend Snippet: a Schematic depicting the hypothesis that AJSZ promotes the expression of reprogramming barriers. b Volcano plot showing the screening results for siRNAs directed against top 25 percentile downregulated (MGT + siAJSZ vs MGT) and core promoter-bound genes in the iMGT-MEF CR assay. The top three candidate barrier genes are circled. n = 4 per condition. c Histogram showing validation of siNceh1 and siChst2 effect on CR. n = 8 per condition. d Representative images for siControl, siChst2, and siNceh1 conditions. Myh6-eGFP+ cells are shown in green and cell nuclei are stained blue (DAPI, top right insets). e Schematic depicting the hypothesis that AJSZ negatively regulates reprogramming agonists. f Volcano plot showing the screening results for siRNAs directed against the top 25 percentile of upregulated (MGT + siAJSZ vs MGT) and core promoter-bound genes in siAJSZ-induced iMGT-MEF assay. g Histogram showing validation of top nine siRNAs that blunt siAJSZ-induced CR without affecting cell viability. n = 4 per condition. h Representative images for siAJSZ+ siControl, siMef2c, siHspb3, or siOlfml3 conditions. i Heatmap summarizing AJSZ expression dependence of identified barriers and agonists in HAECs and HDFs, 2 days after MGT, ABM, or OKSM overexpression. j Model showing that AJSZ regulates cell fate reprogramming by controlling the expression of a conserved set reprogramming agonists. Scale bars: 50 µm. Student’s t -test. * p < 0.05, ** p < 0.01, and **** p < 0.0001. Groups were compared using two-tailed unpaired analysis. Data in the figure are presented as mean values ± standard deviation. j Schematic is modified from Cunningham, T. J. et al. Id genes are essential for early heart formation. Genes & development, 10.1101/gad.300400.117 (2017). - CC-BY 4.0.

    Article Snippet: Human adult aortic endothelial cells (HAECs) were obtained from ATCC (PCS-100-011) and cultured in plates precoated with 0.1% gelatin in Vascular Cell Basal Medium (VCBM; ATCC, PCS-100-030) containing endothelial cell growth kit-BBE (ATCC, PCS-100-040) and 0.1% P/S.

    Techniques: Expressing, Biomarker Discovery, Staining, Over Expression, Two Tailed Test, Standard Deviation, Modification